Seminars in Arthritis and Rheumatism 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Editorial Board
(Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - November 4, 2017 Category: Rheumatology Source Type: research
Table of Contents
(Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - November 4, 2017 Category: Rheumatology Source Type: research
Information for Contributors
(Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - November 4, 2017 Category: Rheumatology Source Type: research
Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases
Bullous systemic lupus erythematosus (BSLE) is a rare blistering condition associated with systemic lupus erythematosus (SLE). (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - November 4, 2017 Category: Rheumatology Authors: Tullia de Risi-Pugliese, Fleur Cohen Aubart, Julien Haroche, Philippe Moguelet, Sabine Grootenboer-Mignot, Alexis Mathian, Saskia Ingen-Housz-Oro, Miguel Hie, No émie Wendremaire, Françoise Aucouturier, François Lepelletier, Makoto Miyara, Brigitte Bad Source Type: research
Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: a 128-patients series including 10 new cases ☆
Bullous systemic lupus erythematosus (BSLE) is a rare blistering condition associated with systemic lupus erythematosus (SLE). (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - November 4, 2017 Category: Rheumatology Authors: Tullia de Risi, Fleur Cohen Aubart, Philippe Moguelet, Julien Haroche, Sabine Grootenboer-Mignot, Alexis Mathian, Saskia Oro, Miguel Hie, No émie Wendremaire, Françoise Aucouturier, François Lepelletier, Makoto Miyara, Brigitte Bader-Meunier, Philippe Source Type: research
Footwear interventions for foot pain, function, impairment and disability for people with foot and ankle arthritis: A literature review
To conduct a literature review on the effectiveness of footwear on foot pain, function, impairment and disability for people with foot and ankle arthritis. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - November 3, 2017 Category: Rheumatology Authors: Mike Frecklington, Nicola Dalbeth, Peter McNair, Peter Gow, Anita Williams, Matthew Carroll, Keith Rome Source Type: research
The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab
IL-6 contributes significantly to the chronic inflammatory process of rheumatoid arthritis (RA). Tocilizumab, a humanized anti-human IL-6 receptor antibody that blocks the signaling originated by the IL-6/IL-6R complex, is an effective treatment. However, predictors of the response to tocilizumab are still required. We aimed to combine IL-6 and soluble IL-6R (sIL-6R) levels to identify groups of responses. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - November 1, 2017 Category: Rheumatology Authors: Cesar Diaz-Torne, Maria dels Angels Ortiz, Patricia Moya, Maria Victoria Hernandez, Delia Reina, Ivan Castellvi, Juan Jose De Agustin, Diana de la Fuente, Hector Corominas, Raimon Sanmarti, Carlos Zamora, Elisabet Cant ó, Silvia Vidal Source Type: research
The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab
IL-6 contributes significantly to the chronic inflammatory process of rheumatoid arthritis (RA). Tocilizumab, a humanized anti-human IL-6 receptor antibody that blocks the signaling originated by the IL-6/IL-6R complex, is an effective treatment. However, predictors of the response to tocilizumab are still required. We aimed to combine IL-6 and soluble IL-6R (sIL-6R) levels to identify groups of responses (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - November 1, 2017 Category: Rheumatology Authors: Cesar Diaz-Torne, M. Angels Ortiz, Patricia Moya, M. Victoria Hernandez, Delia Reina, Ivan Castellvi, Juan Jose De Agustin, Diana de la Fuente, Hector Corominas, Raimon Sanmarti, Carlos Zamora, Elisabet Cant ó, Silvia Vidal Source Type: research
Considerations for the definition of remission criteria in psoriatic arthritis
This article evaluates proposed criteria for defining remission in PsA and discusses how these criteria can be applied in clinical practice. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - October 31, 2017 Category: Rheumatology Authors: Philip J. Mease, Laura C. Coates Source Type: research
Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden
The aim of this study was to validate the use of survivin for preclinical recognition of rheumatoid arthritis (RA) among patients with unexplained arthralgia. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - October 31, 2017 Category: Rheumatology Authors: Malin C. Erlandsson, Minna Turkkila, Filip Siljehult, Rille Pullerits, Catharina Eriksson, Solbritt Rantap ää-Dahlqvist, Maria I. Bokarewa Source Type: research
Considerations for the Definition of Remission Criteria in Psoriatic Arthritis
This article evaluates proposed criteria for defining remission in PsA and discusses how these criteria can be applied in clinical practice. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - October 31, 2017 Category: Rheumatology Authors: Philip J. Mease, Laura C. Coates Source Type: research
Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden
The aim of this study was to validate the utility of survivin for preclinical recognition of rheumatoid arthritis (RA) among patients with unexplained arthralgia. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - October 31, 2017 Category: Rheumatology Authors: Malin C. Erlandsson, Minna Turkkila, Filip Siljehult, Rille Pullerits, Catharina Eriksson, Solbritt Rantap ää-Dahlqvist, Maria I. Bokarewa Source Type: research
Patient-perceived health service needs in inflammatory arthritis: A systematic scoping review
Care that is patient-centred is more likely to be sustainable and associated with improved health outcomes. This approach to care requires an understanding of patients ’ health service needs, yet few studies have directly investigated the perceived health service needs of people with inflammatory arthritis. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - October 30, 2017 Category: Rheumatology Authors: Julian D. Segan, Andrew M. Briggs, Louisa Chou, Kathryn L. Connelly, Maheeka Seneviwickrama, Kaye Sullivan, Flavia M. Cicuttini, Anita E. Wluka Source Type: research
Rheumatologic symptoms in oncologic patients on PD-1 inhibitors
Immune checkpoint inhibitors are effective cancer therapies that have been associated with immune-related adverse events (irAEs). Recent reports of irAEs describe symptoms resembling classic rheumatologic syndromes, most notably associated with cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibitor blockade. Though cases have been described, there are fewer reports of rheumatologic disease associated with programmed cell death protein-1 (PD-1) inhibitors. Here, we describe a series of four patients presenting to the Brigham and Women ’s Hospital (BWH) Arthritis Center with de novo polymyalgia rheumatica (PMR)-typ...
Source: Seminars in Arthritis and Rheumatism - October 30, 2017 Category: Rheumatology Authors: Wilson F. Kuswanto, Lindsey A. MacFarlane, Lydia Gedmintas, Alexandra Mulloy, Toni K. Choueiri, Bonnie L. Bermas Source Type: research
